Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
Clinical trial NCT00268385 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00268385
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-16
- Primary completion
- 2018-10-18
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.